# |
PMID |
Sentence |
1 |
16517100
|
Identification of a follistatin-related protein from the tick Haemaphysalis longicornis and its effect on tick oviposition.
|
2 |
16517100
|
A gene encoding a follistatin-related protein (FRP) was obtained by random sequencing from the ovary cDNA library of the tick Haemaphysalis longicornis.
|
3 |
16517100
|
The sequence shows homology with the follistatin-related protein (FRP), which was thought to play some roles in the negative regulation of cellular growth.
|
4 |
16517100
|
The recombinant proteins were found to have binding activity for both activin A and bone morphogenetic protein-2 (BMP-2).
|
5 |
16517100
|
Identification of a follistatin-related protein from the tick Haemaphysalis longicornis and its effect on tick oviposition.
|
6 |
16517100
|
A gene encoding a follistatin-related protein (FRP) was obtained by random sequencing from the ovary cDNA library of the tick Haemaphysalis longicornis.
|
7 |
16517100
|
The sequence shows homology with the follistatin-related protein (FRP), which was thought to play some roles in the negative regulation of cellular growth.
|
8 |
16517100
|
The recombinant proteins were found to have binding activity for both activin A and bone morphogenetic protein-2 (BMP-2).
|
9 |
16517100
|
Identification of a follistatin-related protein from the tick Haemaphysalis longicornis and its effect on tick oviposition.
|
10 |
16517100
|
A gene encoding a follistatin-related protein (FRP) was obtained by random sequencing from the ovary cDNA library of the tick Haemaphysalis longicornis.
|
11 |
16517100
|
The sequence shows homology with the follistatin-related protein (FRP), which was thought to play some roles in the negative regulation of cellular growth.
|
12 |
16517100
|
The recombinant proteins were found to have binding activity for both activin A and bone morphogenetic protein-2 (BMP-2).
|
13 |
18156495
|
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production.
|
14 |
18156495
|
Human monocyte-derived DCs (MoDCs) and the CD1c(+) and CD123(+) peripheral blood DC populations express both activin-A and the type I and II activin receptors.
|
15 |
18156495
|
Furthermore, MoDCs and CD1c(+) myeloid DCs rapidly secrete high levels of activin-A after exposure to bacteria, specific toll-like receptor (TLR) ligands, or CD40 ligand (CD40L).
|
16 |
18156495
|
Blocking autocrine activin-A signaling in DCs using its antagonist, follistatin, enhanced DC cytokine (IL-6, IL-10, IL-12p70, and tumor necrosis factor-alpha [TNF-alpha]) and chemokine (IL-8, IP-10, RANTES, and MCP-1) production during CD40L stimulation, but not TLR-4 ligation.
|
17 |
24211168
|
Inhibin and follistatin are known to reduce fecundity by inhibiting the actions of activin and FSH.
|
18 |
25101545
|
Fluoxetine administered in drinking water at a dose of 80 mg/l, 5 days before BCG and for 2 more weeks resulted in significant decrease in total immobility time during FST and TST and in cerebral PGE2 and NO levels.
|
19 |
25101545
|
Both ibuprofen (200 mg/l) and L-NAME (1 g/l) administered in drinking water 24 h before BCG and for 2 more weeks resulted in decrease in the total immobility time during FST and TST and in cerebral PGE2 and NO levels, which was comparable to fluoxetine's effect.
|
20 |
25101545
|
On the other hand, l-arginine administered at a dose of 6 g/l in drinking water together with ibuprofen or fluoxetine reversed their effect on FST, TST and cerebral PGE2 and NO levels.
|
21 |
25101545
|
Immunohistochemistry showed a decrease in COX-1 and i-NOS immunoreactivity in the CA1 and CA3 areas of the hippocampus following ibuprofen treatment.
|
22 |
25101545
|
Fluoxetine administered in drinking water at a dose of 80 mg/l, 5 days before BCG and for 2 more weeks resulted in significant decrease in total immobility time during FST and TST and in cerebral PGE2 and NO levels.
|
23 |
25101545
|
Both ibuprofen (200 mg/l) and L-NAME (1 g/l) administered in drinking water 24 h before BCG and for 2 more weeks resulted in decrease in the total immobility time during FST and TST and in cerebral PGE2 and NO levels, which was comparable to fluoxetine's effect.
|
24 |
25101545
|
On the other hand, l-arginine administered at a dose of 6 g/l in drinking water together with ibuprofen or fluoxetine reversed their effect on FST, TST and cerebral PGE2 and NO levels.
|
25 |
25101545
|
Immunohistochemistry showed a decrease in COX-1 and i-NOS immunoreactivity in the CA1 and CA3 areas of the hippocampus following ibuprofen treatment.
|
26 |
25101545
|
Fluoxetine administered in drinking water at a dose of 80 mg/l, 5 days before BCG and for 2 more weeks resulted in significant decrease in total immobility time during FST and TST and in cerebral PGE2 and NO levels.
|
27 |
25101545
|
Both ibuprofen (200 mg/l) and L-NAME (1 g/l) administered in drinking water 24 h before BCG and for 2 more weeks resulted in decrease in the total immobility time during FST and TST and in cerebral PGE2 and NO levels, which was comparable to fluoxetine's effect.
|
28 |
25101545
|
On the other hand, l-arginine administered at a dose of 6 g/l in drinking water together with ibuprofen or fluoxetine reversed their effect on FST, TST and cerebral PGE2 and NO levels.
|
29 |
25101545
|
Immunohistochemistry showed a decrease in COX-1 and i-NOS immunoreactivity in the CA1 and CA3 areas of the hippocampus following ibuprofen treatment.
|